ULBI Stock Forecast 2025-2026
Distance to ULBI Price Targets
ULBI Price Momentum
10 Quality Stocks Worth Considering Now
Researching Ultralife (ULBI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ULBI and similar high-potential opportunities.
Latest ULBI Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, ULBI has a bullish consensus with a median price target of $14.00 (ranging from $14.00 to $14.00). Currently trading at $5.45, the median forecast implies a 156.9% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Josh Sullivan at Benchmark, projecting a 156.9% upside. Conversely, the most conservative target is provided by Josh Sullivan at Benchmark, suggesting a 156.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ULBI Analyst Ratings
ULBI Price Target Range
Latest ULBI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ULBI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | Josh Sullivan | Buy | Reiterates | $14.00 |
| Jun 27, 2024 | Benchmark | Josh Sullivan | Buy | Maintains | $14.00 |
| Mar 5, 2024 | Benchmark | Josh Sullivan | Buy | Maintains | $13.00 |
| Aug 8, 2023 | Benchmark | Josh Sullivan | Buy | Reiterates | $12.00 |
| Mar 26, 2021 | Benchmark | Josh Sullivan | Buy | Initiates | $12.00 |
| May 2, 2013 | Ardour Capital | Reduce | Downgrade | $0.00 |
Ultralife Corporation (ULBI) Competitors
The following stocks are similar to Ultralife based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ultralife Corporation (ULBI) Financial Data
Ultralife Corporation has a market capitalization of $91.45M with a P/E ratio of 10.2x. The company generates $165.15M in trailing twelve-month revenue with a 5.4% profit margin.
Revenue growth is -9.6% quarter-over-quarter, while maintaining an operating margin of +2.1% and return on equity of +7.0%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Ultralife Corporation (ULBI) Business Model
About Ultralife Corporation
Develops innovative battery and communication solutions.
Ultralife Corporation generates revenue by designing, manufacturing, and marketing high-performance power solutions, including lithium-ion batteries and energy storage systems. Their products cater to critical sectors such as military, medical, and industrial applications, ensuring reliability and efficiency in essential operations.
The company is committed to innovation and quality, holding a significant market position. Ultralife also provides advanced communication solutions that enhance connectivity for security and emergency services, supporting both defense and civilian needs while advancing technological capabilities.
Company Information
Sector
Industrials
Industry
Electrical Equipment & Parts
Employees
536
CEO
Mr. Michael E. Manna
Country
United States
IPO Year
1992
Website
www.ultralifecorporation.comUltralife Corporation (ULBI) Latest News & Analysis
Ultralife Corporation (NASDAQ: ULBI) filed a Form 12b-25 with the SEC, notifying a late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
Ultralife Corporation's late filing may signal potential issues with financial reporting or governance, raising concerns about transparency and reliability, which could impact investor confidence and stock performance.
Ultralife Corporation (NASDAQ: ULBI) will report Q4 results on March 11, 2025, later than usual due to the audit of Electrochem Solutions, acquired on October 31, 2024.
Delayed fourth quarter results may signal potential issues with the acquisition integration or financial health of Ultralife Corporation, affecting investor confidence and stock performance.
A company has appointed a Chief Marketing Officer and a Senior Vice President for Sales & Business Development in its Battery & Energy Products division.
New leadership in marketing and sales for Battery & Energy Products signals a strategic focus on growth and innovation, potentially impacting market position and financial performance.
Ultralife Corporation to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
3 months agoUltralife Corporation (NASDAQ:ULBI) will present at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference on December 11, 2024, in New York City.
Ultralife Corporation's presentation at a prominent investor conference may signal growth opportunities and increased visibility, potentially influencing stock performance and investor interest.
Ultralife Corporation (NASDAQ:ULBI) will hold its Q3 2024 earnings conference call on November 8, 2024, at 8:30 AM ET, featuring key executives and analysts.
Ultralife Corporation's Q3 earnings call provides insights into its financial performance and outlook, influencing stock valuation and investor sentiment.
Ultralife Corporation Reports Third Quarter Results
4 months agoUltralife Corporation (NASDAQ: ULBI) announced its third-quarter operating results for the period ending September 30, 2024, on November 8, 2024.
Ultralife Corporation's Q3 results can impact stock performance, affecting investor sentiment, market valuation, and future growth expectations.
Frequently Asked Questions About ULBI Stock
What is Ultralife Corporation's (ULBI) stock forecast for 2025?
Based on our analysis of 2 Wall Street analysts, Ultralife Corporation (ULBI) has a median price target of $14.00. The highest price target is $14.00 and the lowest is $14.00.
Is ULBI stock a good investment in 2025?
According to current analyst ratings, ULBI has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.45. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ULBI stock?
Wall Street analysts predict ULBI stock could reach $14.00 in the next 12 months. This represents a 156.9% increase from the current price of $5.45. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Ultralife Corporation's business model?
Ultralife Corporation generates revenue by designing, manufacturing, and marketing high-performance power solutions, including lithium-ion batteries and energy storage systems. Their products cater to critical sectors such as military, medical, and industrial applications, ensuring reliability and efficiency in essential operations.
What is the highest forecasted price for ULBI Ultralife Corporation?
The highest price target for ULBI is $14.00 from Josh Sullivan at Benchmark, which represents a 156.9% increase from the current price of $5.45.
What is the lowest forecasted price for ULBI Ultralife Corporation?
The lowest price target for ULBI is $14.00 from Josh Sullivan at Benchmark, which represents a 156.9% increase from the current price of $5.45.
What is the overall ULBI consensus from analysts for Ultralife Corporation?
The overall analyst consensus for ULBI is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $14.00.
How accurate are ULBI stock price projections?
Stock price projections, including those for Ultralife Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
